GCV Symposium 2017
Skip Content

15 February 2017

Mercer generates two spinouts

Mercer University has established SynPloid and DD Therapeutics that are each set to commercialise a drug delivery system.

Author: Thierry Heles, editor

Mercer University on Monday announced it had spun out two new companies, SynPloid and DD Therapeutics, that have each developed drug delivery systems.

SynPloid is using bioengineering to create a synthetic chromosome system that could be used to deliver genetic material that attacks tumour cells without harming surrounding tissue. The spinout is based on research by Edward Perkins, associate professor, and Amy Greene, assistant professor, at the Mercer School of Medicine.

The company is currently working on applying that technology to various kinds of breast cancer and orphan genetic diseases. SynPloid’s research is funded by two grants from the National Institutes of Health and a Department of Defense Advance Research Program Award.

DD Therapeutics is based on research conducted by Kevin Murnane, assistant professor of pharmaceutical sciences, and Ajay Banga, chair of pharmaceutical sciences and co-director of the Center for Drug Delivery Research at Mercer’s College of Pharmacy.

The spinout is working on transdermal and nanotechnology-based drug delivery technology that is able to deliver more stable and sustained dosing of treatments for conditions of the central nervous systems, such as ADHD, narcolepsy and substance dependence.

UPenn has also inked a licensing agreement with Kiromic, a biotech company that will exploit a biodegradable nanoparticle oral drug delivery system developed by Martin D’Souza, professor of of pharmaceutical sciences and co-director of the Center for Drug Delivery Research at the College of Pharmacy. 

Copyright Mawsonia Limited 2010. Please don´t cut articles from www.globaluniversityventuring.com or the PDF and redistribute by email or post to the web without written permission.

  • Linkedin
  • Mail
  • Rssfeed
Trial Subscribe now

Latest Magazine

GCV Symposium 2017

Editor’s picks

Most popular


23 April 2017

UniVenture Visions 2017 Symposium – Hong Kong

The Coller Institute of Venture and the AUTM Asia 2017 Conference have announced UniVenture Visions, an exclusive symposium that shall trigger the thinking and discussion necessary to evolve research universities…

23 May 2017

GCV Symposium 2017 - London

Join 400+ business leaders from the corporate venturing and wider high growth business ecosystem for the two-day 2017 GCV Symposium.